top of page


 Thomas M. Kolb, M.D., specializes in the detection and diagnosis of breast cancer in young, predominantly hi-risk premenopausal women and maintains a private practice dedicated to breast health and cancer detection.

Dr Kolb served as an assistant clinical professor of Radiology at Columbia University College of Physicians and Surgeons from 1994-2010 and currently is a supervising preceptor for instructing the surgical fellows at Memorial Sloane Kettering Cancer Center. He  is double board certified, having received his training in pediatrics at the Albert Einstein College of Medicine in Bronx, New York, and in diagnostic radiology at the Columbia-Presbyterian Medical Center in New York.

Dr. Kolb has been on the faculty of numerous medical educational meetings, and he has lectured in the U.S. and internationally on breast cancer detection and diagnosis, (See Lectures section). He either holds or has held positions on the board of directors of the Breast and Prostate Cancer Research Foundation in New York, as chairman of the medical advisory committee of Sharsheret and the medical advisory committee for the Young Survival Coalition. 

Dr. Kolb is an original founder of the New York Breast Cancer Study and was co-author of its research publication "Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2" published in the journal Science in 2003 detailing the clinical effect of breast cancer genetic mutations.

In 1998, Dr. Kolb published the first contemporary prospective study detailing the use of breast ultrasound to detect cancers that are both mammographically and physically occult. His subsequent 2002 publication evaluating 27,825 consecutive patients  was chosen as the scientific paper of the year by the American Medical Association (AMA) science writers group. (See Research section).

Dr. Kolb has been a manuscript reviewer for the journal Radiology. His manuscripts and research interests have focused on the critical evaluation of current breast cancer screening modalities, genetic predispositions to breast cancer, and the use of novel techniques and technologies for the detection and diagnosis of breast cancer.

Dr. Kolb was the principal investigator of the GE North American Digital Breast Tomosynthesis (3D Mammograms)  project trial, and has the highest level of scientific experience with 3D Breast tomosynthesis

Dr. Kolb is a member of numerous professional organizations including the American Roentgen Ray Society, the Radiological Society of North America, the Society of Breast Imaging and the New York Metropolitan Breast Cancer Group. He is a fellow of the American College of Radiology and a fellow of the American Academy of Pediatrics.

bottom of page